Non-contrast Head CT: Initial step in acute focal deficit to rule out hemorrhage before thrombolysis.
CTA of head and neck or MRA of head and neck: Initial diagnostic vascular imaging of choice (rapid, non-invasive, high sensitivity/specificity).
Confirmatory / Gold Standard:
Digital Subtraction Angiography (DSA) / Conventional catheter angiography (gold standard, but largely replaced by CTA/MRA).
Key Imaging Findings:
“String sign” (tapering long-segment stenosis).
“Flame sign” (tapered occlusion).
Crescentic intramural hematoma (seen best on axial T1 fat-saturated MRI).
Intimal flap, false lumen, or pseudoaneurysm.
Key Labs: CBC, PT/INR, PTT, BMP (renal function for CTA contrast), cardiac biomarkers.
Differential Diagnostics
Subarachnoid Hemorrhage (SAH):
Diff by: Sudden-onset “thunderclap” headache, meningismus, subarachnoid hyperdensity on non-contrast CT / RBCs on LP (xanthochromia).
Cluster Headache:
Diff by: Severe retro-orbital pain + autonomic signs (rhinorrhea, lacrimation), but transient/episodic (<3 hours) without focal neurological deficits or mural hematoma on imaging.
Diff by: Absence of headache/Horner syndrome, normal vascular imaging, pain reproduced exclusively by mechanical palpation/movement.
Migraine with Aura:
Diff by: Gradual aura progression (<60 min) followed by pulsating headache with photophobia/nausea; lacks Horner syndrome or vascular imaging abnormalities.
Management
Acute Phase (<4.5 hours from ischemic stroke onset):
IV Alteplase (rtPA) or Tenecteplase: First-line for acute ischemic stroke within 4.5 hours if no contraindications (extracranial dissection is NOT a contraindication).
Endovascular Thrombectomy (EVT): Indicated for acute large vessel occlusion (LVO) of anterior circulation within eligible time windows (up to 24 hours).
Subacute / Maintenance Medical Therapy (First-line):
Antithrombotic Therapy for 3–6 months:
Antiplatelet therapy (e.g., Aspirin monotherapy or DAPT [Aspirin + Clopidogrel]) OR Anticoagulation (e.g., Heparin bridging to Warfarin/DOAC).
Note: Guidelines demonstrate equivalent stroke prevention efficacy between antiplatelet and anticoagulation. Antiplatelet is often preferred due to lower bleeding risk.
Strict BP control (avoid extreme hypertension to prevent hematoma extension; avoid excessive hypotension to maintain cerebral perfusion).